3 things to look out for on Friday
U.S. equities closed lower on Thursday, as the S&P 500 and Nasdaq Composite retreated from the previous sessionâs gains amid broad weakness across global technology shares.
YayaNews contributes financial news and market context through the YayaNews editorial workflow.
3 things to look out for on Friday | Seeking Alpha
Save
Play
(
2min
)
Comments
Alexey_Fedoren
U.S. equities closed lower on Thursday, as the S&P 500 and Nasdaq Composite retreated from the previous sessionâs gains amid broad weakness across global technology shares.
The benchmark S&P 500 (
SP500
) declined -0.5%, while the technology-heavy Nasdaq Composite (
To ensure this doesnât happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please
report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.
Search field
Entering text into the input field will update the search result below
Entering text into the input field will update the search result below
Recommended For You
More
Trending News
See More
»
Original YayaNews editorial coverage, published for informational purposes.
This article is sourced from Seeking Alpha. It is for informational purposes only and does not constitute investment advice.
Topics & Symbols
Continue Reading
Related Reading
American Water's Pennsylvania Subsidiary Secures $749 Million Annual Rate Hike Approval, Boosting Utility Stocks
American Water's Pennsylvania subsidiary received regulatory approval for a $749 million annual rate increase, easing infrastructure investment pressures. Analysts say the decision reinforces the company's defensive investment thesis, with attention on future rate filings.
End of an era? Falling buybacks, rising share counts signal shift in market dynamics (SPY:NYSEARCA)
Buyback era may be ending as S&P 500 share counts rise and repurchases decline, signaling a new capex cycle.
Harmony Biosciences Holdings, Inc. reports preliminary Q2 results (HRMY:NASDAQ)
Harmony Biosciences (HRMY) Q2 revenue hits $261M; 2026 guidance reaffirmed at $1.0Bâ$1.04B. Get key insights before Aug.
Bank7 projects Q3 expenses of $9.5M-$9.7M while M&A process targets September 3 auction end date (NASDAQ:BSVN)
Bank7 (BSVN) Q2 2026 earnings call highlights: core NIM 4.53â4.55%, deposit costs ~2.3%, Q3 expenses guide, loan/M&A outlookâread now.